Source: Artherosclerosis. Unidade: FM
Subjects: INFARTO DO MIOCÁRDIO, ALGORITMOS, CALCIFICAÇÃO FISIOLÓGICA, CORONARIOPATIA, PROTEÍNAS, ARTERIOSCLEROSE (FISIOPATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SPOSITO, Andrei C et al. Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein. Artherosclerosis, v. 214, n. 1, p. 148-150, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2010.10.034. Acesso em: 04 maio 2026.APA
Sposito, A. C., Alvarenga, B. F., Alexandre, A. S., Araújo, A. L. R., Santos, S. N., Andrade, J. M., et al. (2011). Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein. Artherosclerosis, 214( 1), 148-150. doi:10.1016/j.atherosclerosis.2010.10.034NLM
Sposito AC, Alvarenga BF, Alexandre AS, Araújo ALR, Santos SN, Andrade JM, Ramires JAF, Silva JCQ e, Coelho OR. Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein [Internet]. Artherosclerosis. 2011 ; 214( 1): 148-150.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.10.034Vancouver
Sposito AC, Alvarenga BF, Alexandre AS, Araújo ALR, Santos SN, Andrade JM, Ramires JAF, Silva JCQ e, Coelho OR. Most of the patients presenting myocardial infarction would not be eligible for intensive lipid-lowering based on clinical algorithms or plasma C-reactive protein [Internet]. Artherosclerosis. 2011 ; 214( 1): 148-150.[citado 2026 maio 04 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2010.10.034
